应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ABBV 艾伯维公司
盘前交易 08-23 08:23:00 EDT
196.37
-0.16
-0.08%
盘前
196.37
+0.00
0.00%
08:05 EDT
最高
197.54
最低
195.35
成交量
367.67万
今开
197.01
昨收
196.53
日振幅
1.11%
总市值
3,469亿
流通市值
3,462亿
总股本
17.66亿
成交额
7.21亿
换手率
0.21%
流通股本
17.63亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
分析-Ozempic 上榜华尔街 2027 年医疗保险药品谈判名单
Reuters · 23分钟前
分析-Ozempic 上榜华尔街 2027 年医疗保险药品谈判名单
美国研究综述-Advance Auto Parts、Chewy、Workday
Reuters · 16:39
美国研究综述-Advance Auto Parts、Chewy、Workday
艾伯维(ABBV.US)潜在重磅双特异性抗体疗法再获欧盟批准
智通财经 · 08-20 21:12
艾伯维(ABBV.US)潜在重磅双特异性抗体疗法再获欧盟批准
艾伯维上涨1.21%,报196.25美元/股
金融界 · 08-19
艾伯维上涨1.21%,报196.25美元/股
引言-对医疗保险药品降价的反应
Reuters · 08-15
引言-对医疗保险药品降价的反应
美国公布医疗保险药品谈判价格
Reuters · 08-15
美国公布医疗保险药品谈判价格
美国预计首次医疗保险药品价格谈判将节省 60 亿美元
Reuters · 08-15
美国预计首次医疗保险药品价格谈判将节省 60 亿美元
BUZZ-血癌疗法组合在研究中 "不太可能成功",Syros Pharma 公司业绩下滑
Reuters · 08-13
BUZZ-血癌疗法组合在研究中 "不太可能成功",Syros Pharma 公司业绩下滑
当下该投资什么?大摩:购买这些防御性优质股票
老虎资讯综合 · 08-13
当下该投资什么?大摩:购买这些防御性优质股票
大摩:维持AbbVie(ABBV.US)评级
智通财经 · 08-13
大摩:维持AbbVie(ABBV.US)评级
动荡市场中投资哪些股票较安全?这8只股有良好的业绩记录,且估值吸引
老虎资讯综合 · 08-12
动荡市场中投资哪些股票较安全?这8只股有良好的业绩记录,且估值吸引
艾伯维上涨1.21%,报189.78美元/股
金融界 · 08-08
艾伯维上涨1.21%,报189.78美元/股
BUZZ-McKesson 第一季度收入不及预期,业绩下滑
Reuters · 08-08
BUZZ-McKesson 第一季度收入不及预期,业绩下滑
艾伯维上涨1.22%,报186.605美元/股
金融界 · 08-06
艾伯维上涨1.22%,报186.605美元/股
艾伯维下跌3.14%,报183.355美元/股
金融界 · 08-05
艾伯维下跌3.14%,报183.355美元/股
美国研究综述-Arista Networks、Penumbra、S&P Global
Reuters · 08-05
美国研究综述-Arista Networks、Penumbra、S&P Global
摩根士丹利财富管理部门增加了对联合健康、艾伯维公司和斯伦贝谢的内部持有股权比例。
智通财经 · 08-02
摩根士丹利财富管理部门增加了对联合健康、艾伯维公司和斯伦贝谢的内部持有股权比例。
艾伯维上涨3.02%,报190.925美元/股
金融界 · 08-02
艾伯维上涨3.02%,报190.925美元/股
更新版 1-Cigna 因药房福利增长,季度利润超出预期
Reuters · 08-01
更新版 1-Cigna 因药房福利增长,季度利润超出预期
艾伯维公司:重申第三季度摊薄后每股收益指导区间为2.92美元至2.96美元。
智通财经 · 08-01
艾伯维公司:重申第三季度摊薄后每股收益指导区间为2.92美元至2.96美元。
暂无数据
公司概况
公司名称:
艾伯维公司
所属市场:
NYSE
上市日期:
--
主营业务:
艾伯维公司注册成立于2012年4月10日,是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法,来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域,包括类风湿性关节炎,牛皮癣和克罗恩病,银屑病和克罗恩病;低睾酮,HIV,子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。
发行价格:
--
{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":196.37,"timestamp":1724356800000,"preClose":196.53,"halted":0,"volume":3676719,"hourTrading":{"tag":"盘前","latestPrice":196.37,"preClose":196.37,"latestTime":"08:05 EDT","volume":362,"amount":71167.58548,"timestamp":1724414703333},"delay":0,"floatShares":1762884360,"shares":1766343745,"eps":2.98998,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.16,"latestTime":"08-23 08:23:00 EDT","open":197.005,"high":197.54,"low":195.35,"amount":721411241.0214,"amplitude":0.011143,"askPrice":197.15,"askSize":4,"bidPrice":196.23,"bidSize":4,"shortable":3,"etf":0,"ttmEps":2.98998,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724419800000},"adr":0,"adjPreClose":196.37,"adrRate":0,"dividendRate":0.031217,"preHourTrading":{"tag":"盘前","latestPrice":196.37,"preClose":196.37,"latestTime":"08:05 EDT","volume":362,"amount":71167.58548,"timestamp":1724414703333},"postHourTrading":{"tag":"盘后","latestPrice":196.37,"preClose":196.37,"latestTime":"19:23 EDT","volume":907568,"amount":178219068.5666,"timestamp":1724369000755},"volumeRatio":0.8929896581980089,"impliedVol":0.2149,"impliedVolPercentile":0.5339},"requestUrl":"/m/hq/s/ABBV/tweets","defaultTab":"tweets","newsList":[{"id":"2461560288","title":"分析-Ozempic 上榜华尔街 2027 年医疗保险药品谈判名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2461560288","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461560288?lang=zh_cn&edition=full","pubTime":"2024-08-23 20:00","pubTimestamp":1724414417,"startTime":"0","endTime":"0","summary":"监管机构将于 2025 年 2 月公布另外 15 种药物的名单。2022 年,医疗保险在该药物上的支出超过 46 亿美元。\"他将Ozempic列入了面临价格谈判的高折扣产品名单。诺和诺德表示,它保留了 Ozempic 上市价格的 60% 左右。辉瑞至少有两种药品Ibrance和Xtandi可能被列入2027年的名单。2028 年削减 2026 年,监管机构将宣布在 2028 年再对多达 15 种药品进行谈判,其中包括被称为 B 部分的医疗保险医院计划所涵盖的药品,以及此后每年多达 20 种药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU1066053197.SGD","LU1037948897.HKD","LU1244550221.USD","LU1074936037.SGD","LU2125154778.USD","LU1941712264.USD","MRK","LU1934455863.HKD","LU1934455194.USD","BK4139","IE00B2B36J28.USD","LU0306806265.USD","BMY","LU0225284248.USD","LU0985320562.USD","LU0320765489.SGD","LU0985481810.HKD","LU0070302665.USD","IE00BJJMRZ35.SGD","LU2133065610.SGD","ABBV","LU2242652126.USD","LU1291159041.SGD","LU0256863811.USD","LU0708994859.HKD","LU1267930490.SGD","LU0114720955.EUR","PFE","IE00BLSP4452.SGD","LU0106261372.USD","BK4007","LU1934455277.USD","LU0198837287.USD","LU0795875086.SGD","LU0256863902.USD","LU0266013472.USD","IE00B19Z3581.USD","LU0203345920.USD","BK4559","LU0456855351.SGD","LU1718418525.SGD","LU0943347566.SGD","LU0795875169.SGD","LU0306807586.USD","BK4581","IE00B4R5TH58.HKD","LU2242646821.SGD","LU1917777945.USD","LU1244550494.USD"],"gpt_icon":0},{"id":"2461551620","title":"美国研究综述-Advance Auto Parts、Chewy、Workday","url":"https://stock-news.laohu8.com/highlight/detail?id=2461551620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461551620?lang=zh_cn&edition=full","pubTime":"2024-08-23 16:39","pubTimestamp":1724402379,"startTime":"0","endTime":"0","summary":" 路透8月23日 - 周五,华尔街证券分析师修改了几家美国上市公司的评级和目标价,其中包括 Advance Auto Parts、Chewy 和 Workday。要点 * Advance Auto Parts Inc :摩根大通将目标价从55美元下调至43美元 * Chewy :Piper Sandler将其评级从 \"中性 \"上调至 \"增持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BXP","LU1621767810.EUR","PSN","WRBY","WMB","BILL","ROST","IE00BN29S564.USD","LB","ETSY","INTU","DNA","LU2065731478.USD","SHOO","WLK","BJ","NEXN","WDAY","ONON","HCA","RVLV","LU1935043536.SGD","CHWY","FL","IE00B1BXHZ80.USD","VIK","IE0034235303.USD","BK4185","HQI","RRGB","CROX","IE00BSNM7G36.USD","ABBV","SQM","CAVA","ARGX","REGN","LANC","AAP","LU0289739699.SGD","DECK","DKNG"],"gpt_icon":1},{"id":"2460009676","title":"艾伯维(ABBV.US)潜在重磅双特异性抗体疗法再获欧盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2460009676","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460009676?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:12","pubTimestamp":1724159568,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,8月20日,艾伯维和Genmab共同宣布,欧盟委员会已经批准Tepkinly扩展适应症,用于治疗复发或难治性(R/R)滤泡性淋巴瘤成人患者,这些患者先前接受过2线以上的系统性疗法。新闻稿表示,Tepkinly是欧盟批准用于治疗R/R FL和R/R弥漫性大B细胞淋巴瘤的首款皮下注射T细胞接合双特异性抗体。Tepkinly是一种皮下给药,基于Genmab公司专有的DuoBody技术构建的IgG1亚型双特异性抗体。Genmab的DuoBody-CD3技术旨在选择性地引导细胞毒性T细胞向靶细胞类型产生免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1167284.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0198837287.USD","LU0203347892.USD","LU0738911758.USD","LU1430594728.SGD","LU1093756325.SGD","LU0203345920.USD","LU0553294199.USD","IE00B2B36J28.USD","LU0795875086.SGD","LU1291159041.SGD","LU0949170772.SGD","LU0234570918.USD","IE00BFTCPJ56.SGD","LU0689472784.USD","LU1003077747.HKD","LU0029864427.USD","LU0211327993.USD","LU0256863811.USD","LU0170899867.USD","IE00BSNM7G36.USD","LU0114720955.EUR","BK4559","LU0417517546.SGD","BK4566","LU0708994859.HKD","LU1267930490.SGD","LU1093756168.USD","LU1023059063.AUD","BK4533","BK4581","LU0882574055.USD","BK4534","LU0456855351.SGD","LU0122379950.USD","LU0256863902.USD","IE0002141913.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0820561909.HKD","LU1057294990.SGD","LU0795875169.SGD","LU1244550221.USD","IE0009355771.USD","LU0912757837.SGD","LU0943347566.SGD","ABBV","LU0820561818.USD","LU1244550494.USD","LU0310800379.SGD","IE0004445239.USD"],"gpt_icon":0},{"id":"2460030172","title":"艾伯维上涨1.21%,报196.25美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2460030172","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460030172?lang=zh_cn&edition=full","pubTime":"2024-08-19 22:29","pubTimestamp":1724077749,"startTime":"0","endTime":"0","summary":"8月19日,艾伯维(ABBV)盘中上涨1.21%,截至22:29,报196.25美元/股,成交1.33亿美元。财务数据显示,截至2024年06月30日,艾伯维收入总额267.72亿美元,同比增长2.61%;归母净利润27.39亿美元,同比增长21.03%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/19222942500094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0820561909.HKD","LU1057294990.SGD","IE0009355771.USD","LU1093756168.USD","BK4534","BK4585","IE00B2B36J28.USD","LU0949170772.SGD","LU0256863902.USD","LU0912757837.SGD","LU0203347892.USD","IE0004445239.USD","LU0029864427.USD","LU0689472784.USD","IE00BSNM7G36.USD","LU0417517546.SGD","LU0158827948.USD","LU0198837287.USD","LU0985320562.USD","LU0128525929.USD","LU0234570918.USD","LU0820561818.USD","LU0203345920.USD","LU1267930490.SGD","LU1023059063.AUD","BK4588","IE00BJT1NW94.SGD","LU1244550221.USD","LU1291159041.SGD","LU0211327993.USD","LU0170899867.USD","LU1430594728.SGD","IE00BJJMRZ35.SGD","BK4559","LU0795875086.SGD","LU1244550494.USD","LU0122379950.USD","LU0234572021.USD","BK4139","IE00B4R5TH58.HKD","BK4581","LU0256863811.USD","ABBV","LU1244550577.SGD","IE00BFTCPJ56.SGD","LU0738911758.USD","LU0545039389.USD","LU0456855351.SGD","BK4533","LU0661504455.SGD"],"gpt_icon":0},{"id":"2459424102","title":"引言-对医疗保险药品降价的反应","url":"https://stock-news.laohu8.com/highlight/detail?id=2459424102","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459424102?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:05","pubTimestamp":1723727136,"startTime":"0","endTime":"0","summary":" 路透8月15日 - 美国政府周四表示,已通过谈判将美国老年人医疗保险计划中 10 种最畅销处方药的价格下降了多达 79%,从而结束了与制药商长达数月的史无前例的讨论。卡马拉-哈里斯副总统\"今天的声明将改变全美许多人的生活\" \"我们不会止步于此\"\"作为我们医疗保险药品价格谈判计划的一部分,每年还将选择更多的处方药\"。\"保险计划及其药房福利管理者对患者支付的 Eliquis 费用负有最终责任\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU1941712264.USD","LU0198837287.USD","PFE","LU0237698245.USD","LU0943347566.SGD","BK4504","LU0321505868.SGD","LU0820561818.USD","LU1883839398.USD","LU0985481810.HKD","LU0689472784.USD","LU1066051225.USD","LU1196500208.SGD","IE00BFTCPJ56.SGD","LU1551013425.SGD","BK4139","IE00BJLML261.HKD","BMY","LU0882574139.USD","IE0004445239.USD","LU1064131342.USD","LU1551013342.USD","BK4581","LU0861579265.USD","LU0882574055.USD","LU0985320562.USD","SG9999011175.SGD","LU1244550221.USD","BK4592","LU1267930573.SGD","LU0097036916.USD","SG9999003800.SGD","ABBV","LU0553294199.USD","LU1059921491.USD","NVO","LU2112291526.USD","JNJ","LU1221951046.USD","AMGN","LU1221951129.SGD","IE0002141913.USD","LU0211331839.USD","LU1267930490.SGD","LU0640476718.USD","MRK","IE0009355771.USD","LU0823416689.USD","LU0889566641.SGD"],"gpt_icon":1},{"id":"2459599440","title":"美国公布医疗保险药品谈判价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2459599440","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459599440?lang=zh_cn&edition=full","pubTime":"2024-08-15 19:14","pubTimestamp":1723720461,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透8月15日 - 美国 周四公布了有史以来第一次处方药谈判的 最终价格,其中默克公司的 糖尿病药物Januvia的降价幅度最大,达到79%。政府为其医疗保险计划(Medicare)中 10 种最昂贵的药品谈判了 (link) 价格,该计划服务于 65 岁以上的美国人和残疾人,覆盖人数达 6600 万。这些药物包括百时美施贵宝 和辉瑞 的畅销血液稀释剂Eliquis以及默克公司的Januvia。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","MRK","LU0211327993.USD","LU1670711123.USD","LU0006306889.USD","LU0096364046.USD","LU2112291526.USD","LU0289739699.SGD","IE00BJLML261.HKD","IE00B1BXHZ80.USD","BK4007","LU1670710588.SGD","LU1670710661.SGD","BK4534","LU1983299246.USD","BK4532","IE0034235303.USD","BMY","LU0471298694.HKD","LU1551013425.SGD","LU0882574139.USD","LU0079474960.USD","PFE","BK4533","LU0689472784.USD","AMGN","LU0310800379.SGD","LU0882574055.USD","LU1267930573.SGD","JNJ","LU1069344957.HKD","IE0002270589.USD","LU0225771236.USD","LU1571399168.USD","LU0795875169.SGD","LU0985481810.HKD","LU1066051811.HKD","LU1623119135.USD","IE00B19Z3B42.SGD","LU1934455863.HKD","LU0211328371.USD","LU1585245621.USD","BK4585","LU0237698245.USD","LU0820561909.HKD","LU1261432733.SGD","LU1074936037.SGD","BK4516","IE0002141913.USD"],"gpt_icon":1},{"id":"2459410889","title":"美国预计首次医疗保险药品价格谈判将节省 60 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459410889","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459410889?lang=zh_cn&edition=full","pubTime":"2024-08-15 17:00","pubTimestamp":1723712437,"startTime":"0","endTime":"0","summary":"美国政府表示,医疗保险主要为 65 岁及以上的美国人提供服务,该计划所覆盖的人群也将在当年节省 15 亿美元的处方药自付费用。哈里斯在参议院的投票中以平票通过了允许药品价格谈判的法律,没有共和党人支持这项法律。下一轮医疗保险药品价格谈判预计将包括另外 15 种药品,于二月份开始。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","IE00BK4W5L77.USD","LU0158827948.USD","LU0265550946.USD","PFE","LU1162221912.USD","LU1430594728.SGD","BK4504","LU1883839398.USD","BK4588","LU0545039389.USD","LU1196500208.SGD","LU0320765489.SGD","IE00BN8TJ469.HKD","BMY","LU2347655156.SGD","LU1064131342.USD","BK4581","LU0070302665.USD","LU0949170772.SGD","LU0985320562.USD","BK4592","ABBV","LU2133065610.SGD","LU0471298777.SGD","LU0738911758.USD","LU2242646821.SGD","IE00BK4W5M84.HKD","LLY","LU0672654240.SGD","LU1059921491.USD","LU1244550494.USD","NVO","IE00B19Z3581.USD","LU1718418525.SGD","JNJ","LU1221951046.USD","AMGN","LU1221951129.SGD","LU0029864427.USD","LU0640476718.USD","LU1267930730.SGD","MRK","LU0320765059.SGD","IE00B2B36J28.USD","LU1032955483.USD","LU0345770993.USD","LU0889566641.SGD","IE00B7SZLL34.SGD","LU2125154778.USD","LU0345770308.USD"],"gpt_icon":1},{"id":"2459197095","title":"BUZZ-血癌疗法组合在研究中 \"不太可能成功\",Syros Pharma 公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2459197095","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459197095?lang=zh_cn&edition=full","pubTime":"2024-08-13 20:27","pubTimestamp":1723552033,"startTime":"0","endTime":"0","summary":"** SYRS表示,目前已加入该研究的患者将有机会继续参与试验,具体由研究人员决定。** SYRS还在骨髓增生异常综合征患者中测试这种疗法,骨髓增生异常综合征是指骨髓中的造血细胞出现异常时发生的一类癌症。** 截至上一交易日收盘,SYRS 在今年累计下跌约 36","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1267930490.SGD","IE00BFTCPJ56.SGD","LU0198837287.USD","LU0820561909.HKD","SYRS","LU0256863811.USD","LU1061106388.HKD","IE0004445239.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","BK4566","ABBV","LU1093756168.USD","IE0002141913.USD","LU0795875169.SGD","IE0009355771.USD","BK4550","BK4533","LU0708994859.HKD","BUZZ","LU0553294199.USD","LU0943347566.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1003077747.HKD","LU1244550577.SGD","LU0211327993.USD","LU1244550221.USD","LU0122379950.USD","LU0310799852.SGD","LU1093756325.SGD","BK4559","BK4585","LU0211328371.USD","LU0310800379.SGD","LU1496350171.SGD","LU0114720955.EUR","LU0912757837.SGD","LU0661504455.SGD","BK4139","IE00B2B36J28.USD","BK4534","LU0820561818.USD","LU0170899867.USD","BK4588","LU0882574055.USD","LU1267930573.SGD","LU0689472784.USD","LU0128525929.USD"],"gpt_icon":0},{"id":"1138676345","title":"当下该投资什么?大摩:购买这些防御性优质股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1138676345","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138676345?lang=zh_cn&edition=full","pubTime":"2024-08-13 14:52","pubTimestamp":1723531928,"startTime":"0","endTime":"0","summary":"尽管美国主要股指不断创下新高,但摩根士丹利对防御性优质股票的偏好自 6 月份以来只增不减。Wilson 重点介绍了他筛选出的优质和防御性股票名单,这些股票是该公司分析师给予增持评级且长期看好的股票,市值也位列前 1,000 名。Meta的股价今年已上涨超过45%,在公司超出第二季度盈利预期并给出乐观展望后,投资者对该股的看涨情绪持续。摩根士丹利其他防御性和优质股票的首选还包括消费品类公司 $沃尔玛$ 和 $劳氏$ 。","market":"us","thumbnail":"https://community-static.tradeup.com/news/8d6d5143c1ab739fc940815d88c334a5","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/8d6d5143c1ab739fc940815d88c334a5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","MDT","CVS","LOW","NOC","ABBV","TMUS","META","PEG","WMT"],"gpt_icon":1},{"id":"2459936679","title":"大摩:维持AbbVie(ABBV.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2459936679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459936679?lang=zh_cn&edition=full","pubTime":"2024-08-13 08:38","pubTimestamp":1723509499,"startTime":"0","endTime":"0","summary":"大摩:维持AbbVie(ABBV.US)评级,由增持调整至增持评级,目标价由211.00美元调整至218.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130847279f25b013&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130847279f25b013&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABBV"],"gpt_icon":0},{"id":"1143503109","title":"动荡市场中投资哪些股票较安全?这8只股有良好的业绩记录,且估值吸引","url":"https://stock-news.laohu8.com/highlight/detail?id=1143503109","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143503109?lang=zh_cn&edition=full","pubTime":"2024-08-12 10:40","pubTimestamp":1723430413,"startTime":"0","endTime":"0","summary":"对于希望在动荡市场中寻找安全投资机会的投资者来说,有一系列大盘股——特别是医疗保健领域的公司,是有吸引力的投资选择。Humira 用于治疗严重类风湿性关节炎、克罗恩病和溃疡性结肠炎,其第二季度全球净收入较 2023 年同期下降 29.8%,原因是来自廉价生物仿制药的竞争继续拖累销售。不过,该公司管理层表示,部分患者正在转向 AbbVie 的免疫治疗药物 Skyrizi 和 Rinvoq。该股票今年迄今已上涨超过21%,大幅超越了大盘的回报率。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/b925dee54e4c3c1d4390f884b109adb0","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b925dee54e4c3c1d4390f884b109adb0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"动荡市场中哪些股票较安全?这8只股票有着良好的业绩记录,且估值颇具吸引力","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFL","PKG","UNH","AMGN","TMUS","AZO","ABBV","COR"],"gpt_icon":1},{"id":"2457027312","title":"艾伯维上涨1.21%,报189.78美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457027312","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457027312?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:27","pubTimestamp":1723127267,"startTime":"0","endTime":"0","summary":"8月8日,艾伯维(ABBV)盘中上涨1.21%,截至22:27,报189.78美元/股,成交1.15亿美元。财务数据显示,截至2024年06月30日,艾伯维收入总额267.72亿美元,同比增长2.61%;归母净利润27.39亿美元,同比增长21.03%。大事提醒:8月7日,艾伯维2024年二季度累计回购金额13.33亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/08222742194058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1061106388.HKD","IE00B4R5TH58.HKD","LU0689472784.USD","LU0912757837.SGD","IE00BSNM7G36.USD","LU1057294990.SGD","LU0820561818.USD","BK4581","IE0004445239.USD","LU1003077747.HKD","LU0256863902.USD","LU0198837287.USD","LU0949170772.SGD","IE00BJJMRZ35.SGD","BK4534","LU0310799852.SGD","LU0158827948.USD","LU1023059063.AUD","LU1267930573.SGD","LU1496350171.SGD","ABBV","LU0417517546.SGD","LU0661504455.SGD","IE00BJT1NW94.SGD","LU0029864427.USD","LU0170899867.USD","LU0456855351.SGD","LU0882574055.USD","LU0943347566.SGD","LU1244550577.SGD","LU0985320562.USD","BK4566","LU0738911758.USD","LU0795875086.SGD","LU1291159041.SGD","BK4550","LU0553294199.USD","BK4139","LU0211328371.USD","LU0820561909.HKD","LU1496350502.SGD","LU0128525929.USD","LU0708994859.HKD","LU0234572021.USD","LU0122379950.USD","IE00B2B36J28.USD","LU1244550221.USD","LU0234570918.USD","LU0545039389.USD","BK4588"],"gpt_icon":0},{"id":"2457781314","title":"BUZZ-McKesson 第一季度收入不及预期,业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2457781314","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457781314?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:13","pubTimestamp":1723126401,"startTime":"0","endTime":"0","summary":"** MCK 将 2025 年的每股收益预期上调至 31.75 美元至 32.55 美元,而之前为 31.25 美元至 32.05 美元。** Gill补充道:\"我们理解投资者可能会对麦克森第一季度的业绩感到失望,因为该季度的门槛很高,但我们仍然看好MCK的增长前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU0738911758.USD","LU1814569148.SGD","LU1430594728.SGD","LU2468319806.SGD","LU0158827948.USD","LU0795875086.SGD","LU1291159041.SGD","BUZZ","IE00BJJMRZ35.SGD","LU0949170772.SGD","LU0234570918.USD","LU0128525929.USD","LU1244550577.SGD","LU2089984988.USD","LU0029864427.USD","LU0211327993.USD","LU0256863811.USD","IE00BSNM7G36.USD","LU0417517546.SGD","LU0708994859.HKD","LU1585245621.USD","BK4139","LU1093756168.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4533","BK4581","LU0882574055.USD","BK4534","LU0456855351.SGD","LU0122379950.USD","LU0256863902.USD","LU1061106388.HKD","MCK","LU1057294990.SGD","LU0661504455.SGD","BK4588","LU2112291526.USD","LU0251142724.SGD","LU0912757837.SGD","LU0985320562.USD","LU1496350502.SGD","LU0251131958.USD","LU2324357040.USD","ABBV","LU0545039389.USD","LU0234572021.USD","LU1244550494.USD","IE0004445239.USD"],"gpt_icon":1},{"id":"2457029158","title":"艾伯维上涨1.22%,报186.605美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457029158","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457029158?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:26","pubTimestamp":1722954384,"startTime":"0","endTime":"0","summary":"8月6日,艾伯维(ABBV)盘中上涨1.22%,截至22:26,报186.605美元/股,成交1.2亿美元。财务数据显示,截至2024年06月30日,艾伯维收入总额267.72亿美元,同比增长2.61%;归母净利润27.39亿美元,同比增长21.03%。大事提醒:8月5日,艾伯维获Cantor Fitzgerald重申评级Overweight,目标价200美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/06222642119954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0198837287.USD","LU0738911758.USD","LU1430594728.SGD","LU1093756325.SGD","LU0158827948.USD","LU0553294199.USD","IE00B2B36J28.USD","LU0795875086.SGD","LU1291159041.SGD","LU0949170772.SGD","IE00BJJMRZ35.SGD","LU0234570918.USD","LU0128525929.USD","LU1244550577.SGD","LU0310799852.SGD","LU0029864427.USD","LU0211327993.USD","LU0256863811.USD","IE00BSNM7G36.USD","LU1267930573.SGD","BK4559","LU0417517546.SGD","LU0708994859.HKD","BK4139","LU1093756168.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4533","BK4581","LU0882574055.USD","BK4534","LU0456855351.SGD","LU0122379950.USD","LU0256863902.USD","IE0002141913.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0661504455.SGD","BK4588","LU0943347566.SGD","LU0912757837.SGD","LU0985320562.USD","LU1496350502.SGD","LU0211328371.USD","ABBV","LU0545039389.USD","LU0234572021.USD","LU1244550494.USD","IE0004445239.USD"],"gpt_icon":0},{"id":"2457774557","title":"艾伯维下跌3.14%,报183.355美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457774557","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457774557?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:36","pubTimestamp":1722868617,"startTime":"0","endTime":"0","summary":"8月5日,艾伯维(ABBV)盘中下跌3.14%,截至22:36,报183.355美元/股,成交2.73亿美元。财务数据显示,截至2024年06月30日,艾伯维收入总额267.72亿美元,同比增长2.61%;归母净利润27.39亿美元,同比增长21.03%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/05223642073435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE0002141913.USD","LU0417517546.SGD","LU0661504455.SGD","LU0553294199.USD","LU1093756168.USD","ABBV","LU0211327993.USD","LU1496350171.SGD","LU0310799852.SGD","LU0943347566.SGD","LU0158827948.USD","LU0128525929.USD","LU0738911758.USD","LU1057294990.SGD","BK4566","LU1291159041.SGD","LU0949170772.SGD","LU0122379950.USD","LU1061106388.HKD","IE0004445239.USD","LU0795875086.SGD","BK4533","BK4581","LU1244550221.USD","LU0211328371.USD","LU0234572021.USD","LU0708994859.HKD","LU0256863811.USD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0310800379.SGD","LU1244550577.SGD","BK4534","LU1023059063.AUD","LU0912757837.SGD","LU0795875169.SGD","LU0882574055.USD","LU1267930573.SGD","LU0234570918.USD","BK4550","LU0256863902.USD","IE00BJJMRZ35.SGD","LU1003077747.HKD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0820561909.HKD","LU0029864427.USD","LU0545039389.USD","BK4559","IE0009355771.USD"],"gpt_icon":0},{"id":"2457729358","title":"美国研究综述-Arista Networks、Penumbra、S&P Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2457729358","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457729358?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:03","pubTimestamp":1722859399,"startTime":"0","endTime":"0","summary":" 路透8月5日 - 华尔街证券分析师周三修改了对几家美国上市公司的评级和目标价,其中包括 Arista Networks、Penumbra 和 S&P Global。要闻 * 美国塔塔公司 :摩根大通将目标价从230美元上调至240美元 * Arista Networks Inc :摩根大通将目标价从335美元上调至340美元 * Illinois Tool Works Inc :摩根大通将目标价从267美元上调至270美元 * Penumbra Inc :杰富瑞将目标价从280美元下调至215美元 * S&P Global Inc :摩根大通将目标价从550美元上调至565美元 以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ECL","CSR","BYON","AMD","CNO","LU1712237335.SGD","CZR","IE0009355771.USD","ADM","AX","MSFT","LU0426412945.USD","LU1623119135.USD","BGC","AGCO","ATRC","AUB","EXP","GL","CCCS","BMRC","CDP","AMT","EA","DH","BKNG","FRSH","LU","AWI","LU0048573561.USD","ABBV","FSFG","LU0557290698.USD","CNOB","BV","DAWN","FLS","GLW","CVLT","LU0496365809.HKD","AEP","CNC","BY","NVDA","CNX","PLOW","CORT","EQR","IE00BKVL7J92.USD","ALB"],"gpt_icon":1},{"id":"2456231406","title":"摩根士丹利财富管理部门增加了对联合健康、艾伯维公司和斯伦贝谢的内部持有股权比例。","url":"https://stock-news.laohu8.com/highlight/detail?id=2456231406","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456231406?lang=zh_cn&edition=full","pubTime":"2024-08-02 19:01","pubTimestamp":1722596465,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SLB","LU0198837287.USD","IE00BFSS8Q28.SGD","LU0211326755.USD","LU0094547139.USD","IE00B19Z3B42.SGD","LU1720051017.SGD","LU0122376428.USD","LU0320765646.SGD","LU1057294990.SGD","LU0122379950.USD","LU0417517546.SGD","LU0314104364.USD","LU0251132253.USD","LU0689472784.USD","LU0708994859.HKD","IE0002270589.USD","LU0310800379.SGD","LU0109391861.USD","IE0004445239.USD","LU0158827948.USD","BK4179","BK4139","IE00B4JS1V06.HKD","LU0106831901.USD","LU0238689110.USD","SGXZ23171101.USD","LU1548497426.USD","LU0320765489.SGD","LU0545039389.USD","LU1162221912.USD","LU2237438978.USD","LU0882574055.USD","LU0820561818.USD","ABBV","BK4559","LU1291159041.SGD","BK4588","LU0553294199.USD","IE00BFTCPJ56.SGD","IE00B19Z8W00.USD","LU1093756168.USD","IE00B19Z9Z06.USD","UNH","LU0208291251.USD","LU0128525929.USD","159503","LU1244550494.USD","BK4550","LU0368265418.SGD"],"gpt_icon":0},{"id":"2456569104","title":"艾伯维上涨3.02%,报190.925美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2456569104","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456569104?lang=zh_cn&edition=full","pubTime":"2024-08-02 00:38","pubTimestamp":1722530290,"startTime":"0","endTime":"0","summary":"8月2日,艾伯维(ABBV)盘中上涨3.02%,截至00:38,报190.925美元/股,成交5.06亿美元。财务数据显示,截至2024年06月30日,艾伯维收入总额267.72亿美元,同比增长2.61%;归母净利润27.39亿美元,同比增长21.03%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/02003841980205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00BFTCPJ56.SGD","BK4139","BK4550","IE0009355771.USD","LU0114720955.EUR","LU1267930490.SGD","LU1267930573.SGD","LU0795875086.SGD","LU1430594728.SGD","LU1244550221.USD","IE00B4R5TH58.HKD","LU0158827948.USD","LU1093756325.SGD","LU0985320562.USD","LU1003077747.HKD","LU0170899867.USD","LU0256863902.USD","LU0689472784.USD","LU0943347566.SGD","LU0256863811.USD","LU0310799852.SGD","LU0553294199.USD","LU0211327993.USD","ABBV","IE00BSNM7G36.USD","LU0310800379.SGD","LU0456855351.SGD","LU0198837287.USD","LU0417517546.SGD","LU1496350171.SGD","IE00B2B36J28.USD","LU0949170772.SGD","LU1061106388.HKD","BK4581","BK4559","LU0211328371.USD","LU0882574055.USD","BK4585","LU0820561909.HKD","BK4588","LU0795875169.SGD","LU0820561818.USD","BK4566","LU0029864427.USD","LU0708994859.HKD","IE00BJJMRZ35.SGD","LU1496350502.SGD","LU1244550494.USD","LU0234570918.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2456433747","title":"更新版 1-Cigna 因药房福利增长,季度利润超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2456433747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456433747?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:53","pubTimestamp":1722520418,"startTime":"0","endTime":"0","summary":"药房福利服务收入从 188 亿美元猛增 41% 至 266 亿美元,帮助 Cigna 将扣除 5300 万美元投资负面影响的收入推高至 605 亿美元。Cigna在6月份表示,它已开始向使用其专业药房Accredo的患者免费发放艾伯维公司 关节炎药物Humira的近似复制品。Cigna 的管理医疗收入主要来自于管理雇主赞助的医疗保健计划。Cigna 股价在收盘前下跌了 1%,报收于 345 美元。该公司公布的第二季度调整后每股利润为 6.72 美元,高于 LSEG 预期的 6.41 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009356076.USD","LU0316494557.USD","LU0348723411.USD","LU0545039389.USD","SG9999014013.SGD","SG9999014005.SGD","IE00B5TLWC47.USD","LU0107464264.USD","LU1023059063.AUD","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","LU0276348264.USD","IE00BFSS7M15.SGD","IE00B19Z9505.USD","LU0320765059.SGD","LU0061474960.USD","HUM","IE0002270589.USD","LU0058720904.USD","LU0868494617.USD","MA","CNC","UNH","IE00BWXC8680.SGD","BK4527","IE00B19Z3581.USD","IE00B1BXHZ80.USD","LU0072461881.USD","IE00B7KXQ091.USD","IE0004086264.USD","LU0029864427.USD","BK4532","IE00BSNM7G36.USD","ABBV","IE00B894F039.SGD","IE00BZ1G4Q59.USD","LU0070302665.USD","CI","BK4581","LU0061475181.USD","CVS","LU0211326839.USD","LU0158827948.USD","LU0289739699.SGD","LU1244550577.SGD","LU0672654240.SGD","LU0708995401.HKD","BK4106"],"gpt_icon":1},{"id":"2456481504","title":"艾伯维公司:重申第三季度摊薄后每股收益指导区间为2.92美元至2.96美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2456481504","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456481504?lang=zh_cn&edition=full","pubTime":"2024-08-01 20:26","pubTimestamp":1722515181,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0198837287.USD","LU1267930490.SGD","IE00B2B36J28.USD","LU1244550494.USD","BK4581","BK4566","LU0158827948.USD","LU1061106388.HKD","LU1093756325.SGD","LU0738911758.USD","LU0256863811.USD","LU0456855351.SGD","BK4139","BK4550","LU0949170772.SGD","LU1267930573.SGD","LU0820561909.HKD","LU1496350502.SGD","LU0985320562.USD","LU0234570918.USD","LU0689472784.USD","LU0170899867.USD","LU0795875086.SGD","IE00B4R5TH58.HKD","LU0912757837.SGD","IE0004445239.USD","LU0211327993.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1093756168.USD","LU1244550577.SGD","LU1057294990.SGD","LU1291159041.SGD","ABBV","LU0708994859.HKD","LU0545039389.USD","LU0211328371.USD","LU0122379950.USD","LU0256863902.USD","LU0417517546.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","LU0029864427.USD","LU0661504455.SGD","BK4588","LU0128525929.USD","IE00BJT1NW94.SGD","BK4585","LU0882574055.USD","LU0234572021.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":0.1341},{"period":"3month","weight":0.2503},{"period":"6month","weight":0.1026},{"period":"1year","weight":0.3351},{"period":"ytd","weight":0.2671}],"compareEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":0.0044},{"period":"3month","weight":0.0506},{"period":"6month","weight":0.0952},{"period":"1year","weight":0.2555},{"period":"ytd","weight":0.1702}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日,是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法,来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域,包括类风湿性关节炎,牛皮癣和克罗恩病,银屑病和克罗恩病;低睾酮,HIV,子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.023334},{"month":2,"riseRate":0.833333,"avgChangeRate":0.030818},{"month":3,"riseRate":0.75,"avgChangeRate":0.006329},{"month":4,"riseRate":0.666667,"avgChangeRate":0.015725},{"month":5,"riseRate":0.666667,"avgChangeRate":0.006183},{"month":6,"riseRate":0.5,"avgChangeRate":0.00974},{"month":7,"riseRate":0.5,"avgChangeRate":0.01182},{"month":8,"riseRate":0.5,"avgChangeRate":-0.001373},{"month":9,"riseRate":0.454545,"avgChangeRate":0.007981},{"month":10,"riseRate":0.636364,"avgChangeRate":0.011149},{"month":11,"riseRate":0.818182,"avgChangeRate":0.080758},{"month":12,"riseRate":0.727273,"avgChangeRate":0.032678}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}